Jonathan Yong
Stock Analyst at UBS
(2.73)
# 1,706
Out of 5,182 analysts
95
Total ratings
62.96%
Success rate
12.58%
Average return
Main Sectors:
Stocks Rated by Jonathan Yong
| Stock | Action | Price Target | Current | Upside | Ratings | Updated | |
|---|---|---|---|---|---|---|---|
| OSCR Oscar Health | Upgrades: Neutral | $12 → $17 | $12.97 | +31.07% | 10 | Jan 9, 2026 | |
| EHTH eHealth | Maintains: Neutral | $7 → $5 | $1.44 | +247.22% | 6 | Aug 7, 2025 | |
| CLOV Clover Health Investments | Maintains: Neutral | $4.5 → $3 | $1.90 | +57.89% | 4 | Aug 6, 2025 | |
| EHAB Enhabit | Maintains: Neutral | $15 → $12 | $13.99 | -14.22% | 3 | Aug 11, 2023 | |
| GDRX GoodRx Holdings | Maintains: Neutral | $7 → $8 | $2.05 | +290.24% | 4 | Aug 10, 2023 | |
| CCRN Cross Country Healthcare | Maintains: Neutral | $27 → $26 | $9.86 | +163.69% | 2 | Aug 8, 2023 | |
| HIMS Hims & Hers Health | Reiterates: Outperform | $14 | $19.50 | -28.21% | 3 | Aug 8, 2023 | |
| HSIC Henry Schein | Reiterates: Outperform | $96 | $73.85 | +29.99% | 3 | Aug 8, 2023 | |
| SEM Select Medical Holdings | Maintains: Neutral | $29 → $32 | $16.35 | +95.72% | 3 | Aug 7, 2023 | |
| AMN AMN Healthcare Services | Maintains: Outperform | $115 → $105 | $18.63 | +463.61% | 4 | Aug 4, 2023 | |
| XXXX XXXXXXXXXXXXXXXX Upgrade | Maintains: Outperform | $76 → $80 | $105.67 | -24.29% | 3 | Aug 4, 2023 | |
| XXXX XXXXXXXXXXXXXXXX Upgrade | Maintains: Outperform | $247 → $231 | $269.17 | -14.18% | 6 | Aug 2, 2023 | |
| XXXX XXXXXXXXXXXXXXXX Upgrade | Reiterates: Neutral | $27 | $5.32 | +407.52% | 5 | Jul 26, 2023 | |
| XXXX XXXXXXXXXXXXXXXX Upgrade | Maintains: Neutral | $90 → $100 | $212.77 | -53.00% | 2 | Jun 12, 2023 | |
| XXXX XXXXXXXXXXXXXXXX Upgrade | Maintains: Outperform | $430 → $450 | $856.62 | -47.47% | 3 | May 12, 2023 | |
| XXXX XXXXXXXXXXXXXXXX Upgrade | Maintains: Neutral | $15 → $12 | $1.07 | +1,021.50% | 3 | May 5, 2023 | |
| XXXX XXXXXXXXXXXXXXXX Upgrade | Maintains: Neutral | $80 → $70 | $5.34 | +1,210.86% | 2 | May 4, 2023 | |
| XXXX XXXXXXXXXXXXXXXX Upgrade | Maintains: Neutral | $14 → $17 | $18.82 | -9.67% | 2 | Apr 28, 2023 | |
| XXXX XXXXXXXXXXXXXXXX Upgrade | Maintains: Outperform | $347 → $350 | $141.53 | +147.30% | 3 | Apr 28, 2023 | |
| XXXX XXXXXXXXXXXXXXXX Upgrade | Maintains: Outperform | $93 → $95 | $25.39 | +274.16% | 1 | Apr 28, 2023 | |
| XXXX XXXXXXXXXXXXXXXX Upgrade | Maintains: Underperform | $7 → $8.5 | $1.16 | +632.76% | 2 | Apr 4, 2023 | |
| XXXX XXXXXXXXXXXXXXXX Upgrade | Reiterates: Outperform | $41 | $22.38 | +83.20% | 2 | Mar 7, 2023 | |
| XXXX XXXXXXXXXXXXXXXX Upgrade | Maintains: Neutral | $3.3 → $8.5 | $3.03 | +180.53% | 2 | Feb 17, 2023 | |
| XXXX XXXXXXXXXXXXXXXX Upgrade | Reiterates: Outperform | $85 | $82.96 | +2.46% | 1 | Feb 16, 2023 | |
| XXXX XXXXXXXXXXXXXXXX Upgrade | Maintains: Neutral | $143 → $146 | $196.81 | -25.82% | 1 | Jan 25, 2023 | |
| XXXX XXXXXXXXXXXXXXXX Upgrade | Maintains: Outperform | $104 → $106 | $36.31 | +191.93% | 3 | Dec 19, 2022 | |
| XXXX XXXXXXXXXXXXXXXX Upgrade | Maintains: Outperform | $129 → $157 | $180.61 | -13.07% | 1 | Nov 25, 2022 | |
| XXXX XXXXXXXXXXXXXXXX Upgrade | Maintains: Outperform | $329 → $368 | $274.25 | +34.18% | 2 | Nov 7, 2022 | |
| XXXX XXXXXXXXXXXXXXXX Upgrade | Maintains: Outperform | $548 → $635 | $197.15 | +222.09% | 2 | Nov 3, 2022 | |
| XXXX XXXXXXXXXXXXXXXX Upgrade | Maintains: Outperform | $113 → $117 | $78.22 | +49.58% | 2 | Aug 8, 2022 | |
| XXXX XXXXXXXXXXXXXXXX Upgrade | Maintains: Outperform | $31 → $30 | $21.74 | +37.99% | 1 | May 3, 2022 | |
| XXXX XXXXXXXXXXXXXXXX Upgrade | Maintains: Outperform | $267 → $298 | $489.58 | -39.13% | 1 | Oct 25, 2021 | |
| XXXX XXXXXXXXXXXXXXXX Upgrade | Maintains: Outperform | $88 → $95 | $194.60 | -51.18% | 2 | Oct 22, 2021 | |
| XXXX XXXXXXXXXXXXXXXX Upgrade | Maintains: Outperform | $462 → $495 | $307.73 | +60.86% | 1 | Oct 15, 2021 |
Oscar Health
Jan 9, 2026
Upgrades: Neutral
Price Target: $12 → $17
Current: $12.97
Upside: +31.07%
eHealth
Aug 7, 2025
Maintains: Neutral
Price Target: $7 → $5
Current: $1.44
Upside: +247.22%
Clover Health Investments
Aug 6, 2025
Maintains: Neutral
Price Target: $4.5 → $3
Current: $1.90
Upside: +57.89%
Enhabit
Aug 11, 2023
Maintains: Neutral
Price Target: $15 → $12
Current: $13.99
Upside: -14.22%
GoodRx Holdings
Aug 10, 2023
Maintains: Neutral
Price Target: $7 → $8
Current: $2.05
Upside: +290.24%
Cross Country Healthcare
Aug 8, 2023
Maintains: Neutral
Price Target: $27 → $26
Current: $9.86
Upside: +163.69%
Hims & Hers Health
Aug 8, 2023
Reiterates: Outperform
Price Target: $14
Current: $19.50
Upside: -28.21%
Henry Schein
Aug 8, 2023
Reiterates: Outperform
Price Target: $96
Current: $73.85
Upside: +29.99%
Select Medical Holdings
Aug 7, 2023
Maintains: Neutral
Price Target: $29 → $32
Current: $16.35
Upside: +95.72%
AMN Healthcare Services
Aug 4, 2023
Maintains: Outperform
Price Target: $115 → $105
Current: $18.63
Upside: +463.61%
Aug 4, 2023
Maintains: Outperform
Price Target: $76 → $80
Current: $105.67
Upside: -24.29%
Aug 2, 2023
Maintains: Outperform
Price Target: $247 → $231
Current: $269.17
Upside: -14.18%
Jul 26, 2023
Reiterates: Neutral
Price Target: $27
Current: $5.32
Upside: +407.52%
Jun 12, 2023
Maintains: Neutral
Price Target: $90 → $100
Current: $212.77
Upside: -53.00%
May 12, 2023
Maintains: Outperform
Price Target: $430 → $450
Current: $856.62
Upside: -47.47%
May 5, 2023
Maintains: Neutral
Price Target: $15 → $12
Current: $1.07
Upside: +1,021.50%
May 4, 2023
Maintains: Neutral
Price Target: $80 → $70
Current: $5.34
Upside: +1,210.86%
Apr 28, 2023
Maintains: Neutral
Price Target: $14 → $17
Current: $18.82
Upside: -9.67%
Apr 28, 2023
Maintains: Outperform
Price Target: $347 → $350
Current: $141.53
Upside: +147.30%
Apr 28, 2023
Maintains: Outperform
Price Target: $93 → $95
Current: $25.39
Upside: +274.16%
Apr 4, 2023
Maintains: Underperform
Price Target: $7 → $8.5
Current: $1.16
Upside: +632.76%
Mar 7, 2023
Reiterates: Outperform
Price Target: $41
Current: $22.38
Upside: +83.20%
Feb 17, 2023
Maintains: Neutral
Price Target: $3.3 → $8.5
Current: $3.03
Upside: +180.53%
Feb 16, 2023
Reiterates: Outperform
Price Target: $85
Current: $82.96
Upside: +2.46%
Jan 25, 2023
Maintains: Neutral
Price Target: $143 → $146
Current: $196.81
Upside: -25.82%
Dec 19, 2022
Maintains: Outperform
Price Target: $104 → $106
Current: $36.31
Upside: +191.93%
Nov 25, 2022
Maintains: Outperform
Price Target: $129 → $157
Current: $180.61
Upside: -13.07%
Nov 7, 2022
Maintains: Outperform
Price Target: $329 → $368
Current: $274.25
Upside: +34.18%
Nov 3, 2022
Maintains: Outperform
Price Target: $548 → $635
Current: $197.15
Upside: +222.09%
Aug 8, 2022
Maintains: Outperform
Price Target: $113 → $117
Current: $78.22
Upside: +49.58%
May 3, 2022
Maintains: Outperform
Price Target: $31 → $30
Current: $21.74
Upside: +37.99%
Oct 25, 2021
Maintains: Outperform
Price Target: $267 → $298
Current: $489.58
Upside: -39.13%
Oct 22, 2021
Maintains: Outperform
Price Target: $88 → $95
Current: $194.60
Upside: -51.18%
Oct 15, 2021
Maintains: Outperform
Price Target: $462 → $495
Current: $307.73
Upside: +60.86%